Nia Therapeutics announced publication in Brain Stimulation of the first in vivo validation of its Smart Neurostimulation System (SNS), a wireless, implantable brain-computer interface designed for ...

Cybersecurity experts discuss 2026 predictions, highlighting the rise of AI-driven threats and the need for advanced security ...

LYNX-3, the second pivotal Phase 3 trial in keratorefractive participants with visual disturbances under mesopic, low-contrast conditions, is ongoing with topline results expected in the first half of ...

Bangladesh Media. New Delhi, Jan 3 (IANS) A new government assuming office in Bangladesh after the February 12 general election will have to deal not only with deteriorating law-and-order and overall ...

Company Achieves Clinical Development Milestones in 2025, Advances Program for Future Scale Up and Studies AUSTIN, Texas, Jan. 7, 2026 /PRNewswire/ -- Genprex, Inc.

Cheers to the creative minds. Syracuse is home to many entrepreneurial people who tried new ideas, took risks and succeeded.

Main outcome measures Cumulative time dependent intake of preservatives, including those in industrial food brands, assessed ...

From floodwaters to fragility - The Maravi Post ...

Getting food-shamed by a server isn’t usually on the menu, but one woman’s dinner came with a very blunt side of honesty.

A slew of new labor-related laws, a plastic bag ban, new requirements for tortillas, and more for the Golden State ...

Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human Primates GPX-002 Rejuvenated Exhausted ...

Company Achieves Clinical Development Milestones in 2025, Advances Program for Future Scale Up and StudiesAUSTIN, Texas, Jan.